About MultiPark
Multidisciplinary neuroresearch on Parkinson’s and Alzheimer’s disease
Multidisciplinary research on neurodegenerative diseases and related brain disorders with the aim to better understand, treat, and cure.
A strategic research area with pioneering roots
MultiPark is a strategic research area supported by the Swedish Government since 2010.
We aim to unravel basic disease mechanisms, improve diagnostic and prognostic precision, and develop efficient methods of treatment and care for people affected by neurodegenerative diseases. Building on a tradition of excellence in dopamine research at Lund University, MultiPark was initially mainly focused on Parkinson’s disease. Since then, our research programme has considerably expanded to incorporate Alzheimer´s disease and neurodegenerative conditions leading to cognitive decline, including Huntington´s disease and neurodegeneration secondary to ischemic or traumatic brain injuries.
To understand, treat, and cure
Our main scientific goals are:
- To understand the origins of neurodegeneration and unravel disease mechanisms.
- To develop early and differential diagnostics and prognostics.
- To create new therapeutic approaches for prevention, disease modification, and management of unmet medical needs.
We are convinced that these goals are best achieved in an interdisciplinary and translational collaborative environment.
From molecule to patient
We foster a broad research program bridging all levels of investigation from molecular changes to the real-world human experience of disease. Our researchers gather regularly across disciplines in 12 special interest groups for in-depth discussions and planning of projects ranging from basic experimental studies to therapeutic interventions on the patients' everyday lives and societal participation.
